Chief Scientific Adviser Criticized For Large Investments In Vaccine Developer

chief-scientific-adviser-criticized-for-large-investments-in-vaccine-developer

12-10-20 07:37:00,

By John Vibes

Sir Patrick Vallance, the Chief Scientific Adviser to the Government of the United Kingdom, has been accused of having a conflict of interest, after a recent report revealed that he has a £600,000 stake in GlaxoSmithKline (GSK), the pharmaceutical company that is working to develop a COVID vaccine for the UK government.

Vallance holds 43,111 shares in the company, but what is perhaps more alarming is how he got the shares in the first place. Before getting his job with the UK government, Vallance was the president of GlaxoSmithKline, which illustrates the revolving door that exists between government agencies and the multinational corporations that they claim to be regulating. When Vallance was appointed to the government, he sold £5 million worth of the company’s shares, but still retained a sizeable stake in the company.

GSK is not the only company working to develop a vaccine, there are more than 20 others, but they are certainly one of the leading brands.

A senior Conservative MP and ex-Cabinet minister told The Telegraph that Sir Patrick should have been more forthcoming about his investments in the company.

“The policy of this Government is to try to suppress Covid at every opportunity until we get a vaccine. That makes it more likely that a vaccine will be prioritised by the Government and he happens to be holding shares in one of the leading companies that are developing it. It is a potential conflict of interest,” the MP said.

“If he is making decisions on vaccines and advising the Government on them, then he either needs to divest himself of the shares or make a declaration every time he touches on the subject. In the Commons, every time MPs raise an issue in which there is a registered interest, they have to declare it. Every time he is talking about vaccines or on TV, he should put it on the table,” they added.

A spokesperson for the UK government issued a statement saying that the shares he holds are only a deferred bonus, and that he has followed all of the legal guidelines to avoid a conflict of interest.

“The GCSA has no input into contractual and commercial decisions on vaccine procurement which are taken by Ministers following a robust cross-Government approvals regime,” the spokesperson said.

 » Lees verder

Chief Science Officer for Pfizer Says “Second Wave” Faked on False-Positive COVID Tests, “Pandemic Is Over” – Global Research

chief-science-officer-for-pfizer-says-“second-wave”-faked-on-false-positive-covid-tests,-“pandemic-is-over”-–-global-research

24-09-20 07:14:00,

In a stunning development, a former Chief Science Officer for the pharmaceutical giant Pfizer says “there is no science to suggest a second wave should happen.” The “Big Pharma” insider asserts that false positive results from inherently unreliable COVID tests are being used to manufacture a “second wave” based on “new cases.”

Dr. Mike Yeadon, a former Vice President and Chief Science Officer for Pfizer for 16 years, says that half or even “almost all” of tests for COVID are false positives. Dr. Yeadon also argues that the threshold for herd immunity may be much lower than previously thought, and may have been reached in many countries already.

In an interview last week Dr. Yeadon was asked:

“we are basing a government policy, an economic policy, a civil liberties policy, in terms of limiting people to six people in a meeting…all based on, what may well be, completely fake data on this coronavirus?”

Dr. Yeadon answered with a simple “yes.”

Dr. Yeadon said in the interview that, given the “shape” of all important indicators in a worldwide pandemic, such as hospitalizations, ICU utilization, and deaths, “the pandemic is fundamentally over.”

Yeadon said in the interview:

“Were it not for the test data that you get from the TV all the time, you would rightly conclude that the pandemic was over, as nothing much has happened. Of course people go to the hospital, moving into the autumn flu season…but there is no science to suggest a second wave should happen.”

In a paper published this month, which was co-authored by Yeadon and two of his colleagues, “How Likely is a Second Wave?”, the scientists write:

“It has widely been observed that in all heavily infected countries in Europe and several of the US states likewise, that the shape of the daily deaths vs. time curves is similar to ours in the UK. Many of these curves are not just similar, but almost super imposable.”

In the data for UK, Sweden, the US, and the world, it can be seen that in all cases, deaths were on the rise in March through mid or late April,

 » Lees verder

UK’s chief scientific adviser has £600,000 of shares in vaccine maker contracted by govt – reports

uk’s-chief-scientific-adviser-has-600,000-of-shares-in-vaccine-maker-contracted-by-govt-–-reports

24-09-20 07:12:00,

UK Chief Scientific Adviser Sir Patrick Vallance reportedly holds a bonus of tens of thousands of shares in a pharma giant developing a Covid-19 vaccine for the government. Yet, London says there is no conflict of interest.

Vallance, who also chairs the government’s expert advisory panel on vaccines, appears to have retained over 43,000 shares in GlaxoSmithKline (GSK) – a UK-based multinational pharmaceutical company – worth £600,000, The Telegraph reported.

Also on rt.com
I’ve lost all trust in medical research – the financial muscle of Big Pharma has been busy distorting science during the pandemic

The shareholding appears to be the legacy of his previous job as the head of research and development at the very same company. Over his tenure from 2012 to 2018, Vallance accumulated a total of 404,201 GSK shares worth a whopping £6.1 million in his hands, according to the British media.

However, he sold more than £5 million worth of shares after being appointed to the government. GSK, meanwhile, has entered the global race to provide the world with a vaccine against coronavirus – alongside some 20 other drug manufacturers and research centers. The endeavor might prove quite lucrative, should the company succeed.

The pharma giant working together with another drug manufacturer – Sanofi – has already struck deals with the UK and the US governments to supply them with a Covid-19 vaccine in case its efforts are fruitful. The contract would see GSK providing as many as 60 million doses to the UK and 100 million doses to the US. Washington already reportedly paid the two companies £1.65 million to accelerate their efforts.

Since it received the government contracts, GSK’s share price rose by some two percent. Vallance has meanwhile been busy ensuring that the UK would get enough vaccine doses if GSK is successful and contributing to the vaccine development efforts.

Also on rt.com
10,000 a day contracting Covid-19 in UK says Health Minister Hancock, as he urges people to download new tracing app

Earlier this week, he said that the first doses could be ready as early as by the end of this year, warning, however, that the first half of 2021 would be a more realistic prospect.The revelations sparked suspicions of a potential conflict of interest.

 » Lees verder

NSA Chief Who Oversaw Sweeping Domestic Phone Surveillance Joins Amazon Board As Director

nsa-chief-who-oversaw-sweeping-domestic-phone-surveillance-joins-amazon-board-as-director

10-09-20 07:38:00,

Just days after Amazon published a scathing letter slamming President Trump for not allowing the American multinational tech company to get the $10 billion Joint Enterprise Defense Infrastructure (JEDI) contract, which instead was awarded to Microsoft, Amazon’s board has just appointed former NSA head and retired general of the US Army Keith B. Alexander as a director. 

Alexander will also serve on the board’s audit committee, according to Bloomberg on Wednesday. The company which has long faced criticism and scrutiny over its deep CIA ties and collaboration, especially given its prior $600 million contract with the CIA for cloud computing services, will now have a well-known national security state hawk who was commander of US Cyber Command from May 2010 to March 2014.

Longtime former Director of the National Security Agency Keith B. Alexander

Crucially his tenure as Director of the National Security Agency went for nearly a decade, from August 2005 to March 2014. From there he founded a cybersecurity technology company in 2014, of which he’s still leads as Co-CEO and president, called IronNet Cybersecurity, Inc.

This is the very NSA chief who was the face of the agency’s mass sweeping up of Americans’ communications exposed by Edward Snowden’s leaks. The US Court of Appeals for the Ninth Circuit earlier this month ruled the invasive NSA program was “illegal” and that US officials lied about it.

At the forefront of the years-long attacks on Snowden, who took refuge in Russia while being sought by US authorities on espionage, was Gen. Alexander, who made consistent media appearances to publicly charge that “Snowden betrayed us” and that he “stole secrets”. 

For those keeping score, not only does Amazon own the The Washington Post and oversees the CIA’s Commercial Cloud Enterprise, it now has on its powerful board of directors the most visible figure from the NSA who illegally spied on Americans for the better part of a decade. 

“Alexa, what is everyone in the world doing right now?”

— Btcn Ftrs (@BtcnFtrs) September 9, 2020

And concerning Amazon’s sour grapes, which it’s very much putting out there for public attention, the irony is thick. Here are some choice lines from last Friday’s press release:

We strongly disagree with the DoD’s flawed analysis and imagine it’s important for our nation that the federal government and its elected leaders administer procurements objectively and in a fashion that’s free from political affect.

 » Lees verder